Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer
– Industry veteran strengthens Pyxis team with expertise in clinical development, medical affairs and antibody-drug conjugates (ADCs) – CAMBRIDGE, Mass., Sept. 14, 2021 – Pyxis Oncology (“Pyxis” or the “Company”) today announced the appointment of Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer. “Jay’s track record of success taking oncology ADC programs from discovery […]
Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer Read More »
